Cited by 158Pharmaceutical studies and practicesPharmaceutical industry and healthcarePediatric health and respiratory diseases

Over the counter but no longer under the radar - pediatric cough and cold medications

Open access
Sharfstein, Joshua M., North, Marisa, Serwint, Janet R.·2007·New England Journal of Medicine

Abstract

Dr. Joshua Sharfstein, Marisa North, and Dr. Janet Serwint write that, in October, an FDA advisory committee voted in favor of immediate action against the use of cough and cold medications in children under 6. After the meeting, the major manufacturers of these products announced that they would continue to market these preparations for children between 2 and 5 years of age.

Integrity signals

Registry

Crossref · 10.1056/nejmp0707400

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A review by the FDA identified 123 deaths related to the use of cough or cold products in children under six years of age over the past few decades.

    “and a review by the FDA identified 123 deaths related to the use of such products in children under six years of age over the past few decades (Sharfstein 2007).”

    From Oral antihistamine-decongestant-analgesic combinations for the common cold (2022) · cites this paper as Sharfstein 2007

  • A report from the US Centers for Disease Control and Prevention identified more than 1500 emergency room visits in 2004 and 2005 for children under two years of age who had been given cough or cold products.

    “A report from the US Centers for Disease Control and Prevention identified more than 1500 emergency room visits in 2004 and 2005 for children under two years of age who had been given cough or cold products”

    From Oral antihistamine-decongestant-analgesic combinations for the common cold (2022) · cites this paper as Sharfstein 2007

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 1 · Cited by 158

Authors
Sharfstein, J. M., North, M., & Serwint, J. R.
Affiliations
Johns Hopkins University (US)
Venue
New England Journal of Medicine
Published
2007-12-06
Volume
357
Issue
23
Pages
2321-2324
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2009961936
Cited by
158
References
1
Citations by year
2026: 1 · 2025: 3 · 2024: 5 · 2023: 1 · 2022: 5 · 2021: 7 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 9 · 2016: 5 · 2015: 11 · 2014: 6 · 2013: 12 · 2012: 12
FWCI
16.17
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmaceutical industry and healthcare
  • Health Sciences › Health Professions › Emergency Medical Services › Pediatric health and respiratory diseases
Keywords
over-the-counter drugs, FDA advisory committee, drug regulation, children under 6 years, drug safety, pharmaceutical manufacturers
MeSH terms
Antitussive Agents, Child, Child, Preschool, Common Cold, Cough, Decision Trees, Nonprescription Drugs, Expectorants, Histamine H1 Antagonists, Humans, Infant, United States, United States Food and Drug Administration, Nasal Decongestants, Treatment Outcome, Drug Approval, Advisory Committees, Marketing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review